Søgning på udtrykket 'covid' giver 84 resultater


Dokumenter [11] Sider [3] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19

Sider [3]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…

…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
18.06.2024
. Abstract. . Background and purpose. The persistent progression of pneumonia is a critical determinant of adverse outcomes in patients afflicted with COVID-19. This study aimed to predict personalized COVID-19 pneumonia progression between the duration of two weeks and 1 month after admission by integrating radiological and clinical features. . . . Methods. …
PLoS One Infectious Diseases
18.06.2024
by Hélder Seixas Lima, Unaí Tupinambás, Frederico Gadelha Guimarães . Our study conducts a comprehensive analysis of the Covid-19 pandemic in Brazil, spanning five waves over three years. We employed a novel Susceptible-Infected-Recovered-Dead-Susceptible (SIRDS) model with a fuzzy transition between epidemic periods to estimate time-varying parameters and evaluate case underreporting. The initial basic reproduction number (R0) is identified at 2.44 (95% Confidence Interval (CI): 2.42–2.46), decreasi…
PLoS One Infectious Diseases
18.06.2024
by Pirhossein Kolivand, Peyman Saberian, Jalal Arabloo, Masoud Behzadifar, Fereshteh Karimi, Soheila Rajaie, Morteza Moradipour, Arash Parvari, Samad Azari . Introduction Globally, the COVID-19 pandemic has affected the number of road accidents and deaths caused by them. The present study aimed to identify the effect of this epidemic on traffic accidents and their casualties in Iran. Methods In this study, Interrupted Time Series Analysis (ITSA) was used in a semi-experimental design to measure the impact…
BMJ Open
17.06.2024
. Introduction. In 2020, the UK government established a large-scale testing programme to rapidly identify individuals in England who were infected with SARS-CoV-2 and had COVID-19. This comprised part of the UK government’s COVID-19 response strategy, to protect those at risk of severe COVID-19 disease and death and to reduce the burden on the health system. To assess the success of this approach, the UK Health Security Agency (UKHSA) commissioned an independent evaluation of the activities delivered by …
BMC Infectious Diseases
17.06.2024
. Abstract. . Background. As an emerging infectious disease with a heterogenous and uncertain transmission pattern, coronavirus disease 2019 (COVID-19) has created a catastrophe in healthcare-associated infections (HAIs) and posed a significant challenge to infection control practices (ICPs) in healthcare settings. While the unique characteristics of psychiatric patients and clinical settings may make the implementation of I…
Emerg Microbes Infect
16.06.2024
Volume 13, Issue 1, December 2024 .
Infection
15.06.2024
. Abstract. . Objectives. To determine the impact of the COVID-19 pandemic on the incidence rates of infection and islet autoimmunity in children at risk for type 1 diabetes. . . . Methods. 1050 children aged 4 to 7 months with an elevated genetic risk for type 1 diabetes were recruited from Germany, Poland, Sweden, Belgium and the UK. Reported infection ep…
Journal of Medical Virology
15.06.2024
Journal of Medical Virology, Volume 96, Issue 6, June 2024.
PLoS One Infectious Diseases
15.06.2024
…gh-Verdeflor, Michelle M. Kelly, Daniel J. Sklansky, Kristin A. Shadman, M. Bruce Edmonson, Qianqian Zhao, Gregory P. DeMuri, Ryan J. Coller . Objectives Children with medical complexity experienced health disparities during the coronavirus disease 2019 (COVID-19) pandemic. Language may compound these disparities since people speaking languages other than English (LOE) also experienced worse COVID-19 outcomes. Our objective was to investigate associations between household language for children with medica…
Infection
14.06.2024
. Abstract. . Objectives. To determine the impact of the COVID-19 pandemic on the incidence rates of infection and islet autoimmunity in children at risk for type 1 diabetes. . . . Methods. 1050 children aged 4 to 7 months with an elevated genetic risk for type 1 diabetes were recruited from Germany, Poland, Sweden, Belgium and the UK. Reported infection ep…
International Journal of Infectious Diseases
14.06.2024
To prevent severe outcomes in SARS-CoV-2 infected individuals, a novel monoclonal antibody COVID-19 treatment—sotrovimab, was approved by Health Canada beginning on July 30th, 2021 [1]. Although antibody therapy was a crucial line of defense in keeping individuals out of hospitals early in the pandemic [2], following waning efficacy of neutralizing acitivty, Health Canada suspended the use of sotrovimab beginning on April 14, 2022, for confirmed COVID-19 BA.2 cases based on in vitro findings [3].
BMC Infectious Diseases
14.06.2024
…Introduction. Respiratory Syncytial Virus (RSV) is a leading cause of acute lower respiratory infection in children worldwide. Understanding its prevalence, variations, and characteristics is vital, particularly in the context of the COVID-19 pandemic. . . . Objective. The study aimed to investigate the RSV positivity rate, subtype prevalence, age and gender distribution, symptomatology, and co-infecti…
PLoS One Infectious Diseases
14.06.2024
by Martina Mchenga, Yamikani Ndasauka, Fiskani Kondowe, Jimmy Kainja, Chilungamo M’manga, Limbika Maliwichi, Simunye Nyamali . Introduction The World Health Organization declared COVID-19 as a pandemic in March 2020. COVID-19 has since caused a significant increase in mental health problems at national and global levels. This study assessed the views of key mental health stakeholders regarding the state of mental health service provision in Malawi and the pandemic’s impact on the sector. Methods The s…
BMC Infectious Diseases
13.06.2024
. Abstract. . Background. The impact of COVID-19 infection on the blood system remains to be investigated, especially with those encountering hematological malignancies. It was found that a high proportion of cancer patients are at an elevated risk of encountering COVID-19 infection. Leukemic patients are often suppressed and immunocompromised, which would impact the pathology following COVID-19 infection. Therefore, this re…
PLoS One Infectious Diseases
13.06.2024
by Oswin Chang, Anthony Levitt, Maida Khalid, Sugy Kodeeswaran, Roula Markoulakis . Objective Higher than expected rates of mental health and/or addiction (MHA) concerns have been documented since the onset of the COVID-19 pandemic. A more up-to-date prevalence of MHA outcomes and the factors associated with the occurrence of MHA concerns remains unclear. This study examined the prevalence of MHA outcomes and factors associated with screening positive for symptoms of depression only, anxiety only, and both…
PLoS One Infectious Diseases
13.06.2024
by Sarah E. Brewer, Kaitlyn B. Bertin, Krithika Suresh, Crystal LoudHawk-Hedgepeth, Montelle Tamez, Jenna E. Reno, Bethany M. Kwan, Donald E. Nease . Purpose To understand motivators, concerns, and factors associated with COVID-19 vaccine initiation for adults in five racial/ethnic communities across Colorado. Methods Community-based data collectors surveyed participants from five Colorado communities (urban and rural Latina/o/x, urban Black, rural African American immigrant, and urban American Indian) ab…
PLoS One Infectious Diseases
13.06.2024
by Fengming Chen, Hayato Nakanishi, Yoichi Sekizawa, Sae Ochi, Mirai So . Background During the COVID-19 pandemic, concerns emerged that vaccinated individuals might engage less in infection-preventive behaviors, potentially contributing to virus transmission. This study evaluates the causal effects of COVID-19 vaccination on such behaviors within Japan, highlighting the significance of understanding behavioral dynamics in public health strategies. Methods Utilizing Japan’s age-based vaccination priorit…
BMC Infectious Diseases
12.06.2024
. Abstract. . Background. The impact of COVID-19 infection on the blood system remains to be investigated, especially with those encountering hematological malignancies. It was found that a high proportion of cancer patients are at an elevated risk of encountering COVID-19 infection. Leukemic patients are often suppressed and immunocompromised, which would impact the pathology following COVID-19 infection. Therefore, this re…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
13.06.2024
Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared. . Reuters Health Information
Medscape Infectious Diseases
12.06.2024
A new report defines the infection-associated chronic condition as lasting at least 3 months, with single or multiple symptoms and without need for confirmatory tests. . Medscape Medical News
Medscape Infectious Diseases
11.06.2024
Four years in, while some progress has been made, lack of research, funding, and clinics keeps many physicians playing diagnostic and treatment whack-a-mole. . Medscape Medical News
Medscape Infectious Diseases
6.06.2024
Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor of recommending that COVID-19 vaccines for 2024-25 should target a strain within. . Reuters Health Information
Medscape Infectious Diseases
6.06.2024
Former top U.S. infectious disease expert Dr. Anthony Fauci strongly denied suppressing the theory that COVID-19 originated from a lab leak in China, telling lawmakers he. . Reuters Health Information
Medscape Infectious Diseases
4.06.2024
Without more robust research, long COVID progress will continue to be slow going. A tech entrepreneur (and long COVID sufferer) is working to change that. . Medscape Medical News
Medscape Infectious Diseases
4.06.2024
A pioneer in dysautonomia shares pearls on approaching patients with long COVID and postural orthostatic tachycardia syndrome. . Medscape
Statens Serum Institut
16.05.2024
Nyt studie viser, at efterårets covid-19-vaccine er mindre effektiv over for de nye covid-varianter, der har domineret smittebilledet den forgangne vinter. Men vaccinen har stadig en væsentlig effekt.
Medscape Infectious Diseases
16.05.2024
CDC experts share what clinicians should know about COVID-19 prevention in immunocompromised patients. . CDC Expert Commentary
Medscape Infectious Diseases
15.05.2024
A leading light in immunobiology takes us through long COVID, nasal vaccines, and the next frontier of the field. . Medscape
Medscape Infectious Diseases
8.05.2024
There is no link between the SARS-CoV-2 vaccine and increased risk for new-onset seizure activity, results from a new meta-analysis showed. . Medscape Medical News
Medscape Infectious Diseases
2.05.2024
The mRNA technology enables quick and flexible responses to new variants of pathogens and rapid scale-up in production, said one researcher. . Medscape Medical News
Medscape Infectious Diseases
2.05.2024
Despite safety and effectiveness, COVID vaccination rates remained lower than flu vaccination rates — and resulting death rates put this in a grim light. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Medscape Infectious Diseases
24.04.2024
The opposite was seen in women when compared with matched control individuals without diabetes. . Medscape UK
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes COVID-19 rates, hospitalizations, and vaccination coverage among nursing home residents.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
Medscape Infectious Diseases
18.04.2024
The World Health Organization and around 500 experts have agreed for the first time what it means for a disease to spread through the air, in a bid to avoid the confusion. . Reuters Health Information
ECDC COVID-19 updates
17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.14.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.767 s

Cookies og privatliv